Institutional Manager · CIK 0002111120
MWG Caph Ltd
WASHINGTON, DC · File #028-26492
Latest AUM
$72.4M
Positions
3
Top-10 Concentration
100.0%
Filings
1
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| NEW | BEAM THERAPEUTICS INC | BEAM | +1,266,934 | +$35.1M | $0 |
| NEW | LYELL IMMUNOPHARMA INC | LYEL | +1,008,116 | +$31.0M | $0 |
| NEW | PRIME MEDICINE INC | PRME | +1,792,210 | +$6.2M | $0 |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 20253 pos · $72.4M
Top 3 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | BEAM THERAPEUTICS INC | BEAM | 1,266,934 | $35.1M | 48.53% |
| 2 | LYELL IMMUNOPHARMA INC | LYEL | 1,008,116 | $31.0M | 42.88% |
| 3 | PRIME MEDICINE INC | PRME | 1,792,210 | $6.2M | 8.59% |